Nanogam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nanogam 50 mg/ml inf. sol. i.v. vial

prothya biosolutions netherlands b.v. - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human normal immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Nanogam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nanogam 50 mg/ml inf. sol. i.v. vial

prothya biosolutions netherlands b.v. - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human normal immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Nanogam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nanogam 50 mg/ml inf. sol. i.v. vial

prothya biosolutions netherlands b.v. - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human normal immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Nanogam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nanogam 50 mg/ml inf. sol. i.v. vial

prothya biosolutions netherlands b.v. - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human normal immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Nanogam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nanogam 50 mg/ml inf. sol. i.v. vial

prothya biosolutions netherlands b.v. - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human normal immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

GAMMAPLEX Israel - English - Ministry of Health

gammaplex

kamada ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 5 g / 100 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, and children and adolescents in:- primary immunodeficiency syndromes with impaired antibody production - hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed- hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation- congenital aids with recurrent bacterial infectionsimmunomodulation in adults, and children and adolescents in:- primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count- guillain barré syndrome- kawasaki disease

Octagam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octagam 50 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human polyvalent immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Octagam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octagam 50 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human polyvalent immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

Octagam 50 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

octagam 50 mg/ml inf. sol. i.v. vial

octapharma benelux sa-nv - human normal immunoglobulin 50 mg/ml - solution for infusion - 50 mg/ml - human polyvalent immunoglobulin 50 mg/ml - immunoglobulins, normal human, for intravascular adm.

OCTAGAM Israel - English - Ministry of Health

octagam

dover medical & scientific equipment ltd, israel - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 50 mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: • primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndrome. • children with congenital aids and recurrent bacterial infections. immunomodulatory effect: • idiopathic thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. • guillain barre syndrome. • kawasaki disease. allogeneic bone marrow transplantation.• myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.